SARS-CoV-2 Delta variant infects ACE2 primary human bronchial epithelial cells more efficiently than other variants.
Hongmei Li, Ting Liu, Liping Wang, Minghui Wang, Shaoqing Wang
Author Information
- Hongmei Li: Department of Pathology, Qiqihar Medical University, Qiqihar, China. ORCID
- Ting Liu: Department of Pathology, Qiqihar Medical University, Qiqihar, China.
- Liping Wang: Department of Pathology, Qiqihar Medical University, Qiqihar, China.
- Minghui Wang: Department of Respiratory Medicine, The First Hospital of Qiqihar, Qiqihar, China.
- Shaoqing Wang: Department of Pathology, Qiqihar Medical University, Qiqihar, China.
No abstract text available.
- Am J Pathol. 2022 Feb;192(2):320-331
[PMID: 34774517]
- Eur Respir J. 2015 Apr;45(4):1150-62
[PMID: 25700381]
- J Chem Theory Comput. 2021 Dec 14;17(12):7972-7979
[PMID: 34856802]
- Nature. 2021 Aug;596(7871):276-280
[PMID: 34237773]
- N Engl J Med. 2021 Aug 12;385(7):585-594
[PMID: 34289274]
- Cell. 2020 Sep 3;182(5):1295-1310.e20
[PMID: 32841599]
- Cell Rep. 2022 May 17;39(7):110829
[PMID: 35550680]
Angiotensin-Converting Enzyme 2
COVID-19
Epithelial Cells
Humans
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Angiotensin-Converting Enzyme 2
